Immunophenotyping in myelodysplastic syndromes can add prognostic information to well-established and new clinical scores.

Immunophenotyping in myelodysplastic syndromes can add prognostic information to well-established and new clinical scores.

BACKGROUND: myelodysplastic syndromes (MDS) are a heterogeneous group of hematopoietic clonal disorders. So, prognostic variables are important to separate patients with a similar biology and clinical outcome. We compared the importance of risk stratification in primary MDS of IPSS and WPSS with the...

Full description

Bibliographic Details
Main Authors: Suiellen C Reis-Alves, Fabíola Traina, Guilherme Harada, Paula M Campos, Sara T O Saad, Konradin Metze, Irene Lorand-Metze
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3855682?pdf=render

Internet

http://europepmc.org/articles/PMC3855682?pdf=render

Similar Items